$53,212,199

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

biotechactiveONGOING · MOD OF 2025 CONTRACT

WORK BEGAN2025-02-01·LATEST ACTION2026-03-19·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50125C00002_7505_-NONE-_-NONE-

Award description

MAINTAINING OF EMBRYONATED EGG SUPPLY FOR NON-SEASONAL PRODUCTION OF PANDEMIC VACCINE

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds embryonated egg supply maintenance for non-seasonal pandemic vaccine production under an ongoing 2025 HHS contract.

Sub-sectors

pandemic-vaccinesmanufacturing-infrastructurepandemic-preparedness

Why this matters

Pandemic vaccine production depends on steady egg supply; this contract sustains U.S. manufacturing capacity for rapid outbreak response.

Supply-chain signal

Embryonated egg supply is a critical bottleneck in vaccine manufacturing; supply disruptions directly cascade to vaccine availability.

U.S.–China competition angle

Strengthens U.S. domestic pandemic vaccine autonomy; relevant as China expands vaccine manufacturing and diplomatic leverage globally.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-09. Cost: $0.008984.

Period of performance

Start

2025-02-01

End

2027-01-31

Status

activein 201 days

Recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50125C00002_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.